APA (7th ed.) Citation

Benkert, P., Maleska Maceski, A., Schaedelin, S., Oechtering, J., Zadic, A., Vilchez Gomez, J. F., . . . Müller, S. (2025). Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B‐Cell Depleting Treatment in Multiple Sclerosis. Annals of Neurology, 97(1), 104. https://doi.org/10.1002/ana.27096

Chicago Style (17th ed.) Citation

Benkert, Pascal, et al. "Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression Under B‐Cell Depleting Treatment in Multiple Sclerosis." Annals of Neurology 97, no. 1 (2025): 104. https://doi.org/10.1002/ana.27096.

MLA (9th ed.) Citation

Benkert, Pascal, et al. "Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression Under B‐Cell Depleting Treatment in Multiple Sclerosis." Annals of Neurology, vol. 97, no. 1, 2025, p. 104, https://doi.org/10.1002/ana.27096.